Takakusagi, Y., Sugyo, A., Tsuji, A. B., Sudo, H., Yasunaga, M., Matsumura, Y., . . . Higashi, T. (2022). The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3. Elsevier.
Style de citation Chicago (17e éd.)Takakusagi, Yoichi, Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Masahiro Yasunaga, Yasuhiro Matsumura, Fumio Sugawara, Kengo Sakaguchi, et Tatsuya Higashi. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.
Style de citation MLA (8e éd.)Takakusagi, Yoichi, et al. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.